Wednesday, September 9, 2009

The SEC has filed charges CellCyte Genetics Corporation its former CEO, and its former Chief Scientific Officer for falsely telling investors that the company's cutting-edge stem cell technology had been proven successful and was headed for human trials. More>>>

Total Pageviews

Nothing on this site is legal advice. Nor does viewing this site or communicating with the authors through the site form an attorney client relationship. This blog is intended to provide information to the public, but may be deemed by the New York Courts to be an advertisement. If so, we are required by New York Court Rule 1200.7 to state "Attorney Advertising. Prior results do not guarantee a similar outcome." The blog is part of the online legal information site SECLaw.com - The Securities Law Home Page, and the product of the work of securities lawyer Mark J. Astarita and the securities law firm of Sallah Astarita & Cox, LLC, with offices in New York, New Jersey and Florida.